萬豪度假環球 VAC 深 滬
已收盤 10-17 16:00:00 美东时间
66.88
-0.150
-0.22%
華盛通- 最 高67.71
- 今 開66.84
- 成交量 25.44万股
- 最 低 66.54
- 昨 收 67.03
- 總市值 23.14亿
- 52周最高 97.16
- 市盈率 靜 11.88
- 換手率 0.74%
- 52周最低 47.64
- 委 比 0.00%
- 總股本 3460.25万
- 歷史最高 178.95
- 量 比 0.76
- 振 幅 1.75%
- 歷史最低 -4.35
- 每 手 1
- 風險率 9.35%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sealed Air Declares Quarterly Cash Dividend
CHARLOTTE, N.C., Oct. 15, 2025 /PRNewswire/ -- Sealed Air Corporation (NYSE: SEE) announced today that its Board of Directors has declared a quarterly cash dividend of $0.20 per common share...
10-16 04:25
盘点农业生物制剂领域十大战略性合作！涉及拜耳、科迪华、巴斯夫、先正达······
近年来，农业生物制剂市场规模呈指数增长态势，这主要得益于成熟的农化公司与生物技术创新企业之间的战略合作。从对开创基因组编辑微生物初创企业的投资，到先进微生物肽...
10-15 18:58
强强联合！英伟达携手合作伙伴，为Vera Rubin打造下一代高效千兆瓦AI工厂
Open Compute Project全球峰会上，英伟达勾勒了千兆瓦级 AI 工厂未来蓝图。 美东时间10月13日，$英伟达 (NVDA.US)$正式公布...
10-14 05:22
Navitas Semiconductor Reveals Progress In Its Development Of Advanced Medium And High 800 VDC Voltage GaN And SiC Power Devices To Enable The 800 VDC Power Architecture Announced By Nvidia For Next-generation AI Factory Computing Platforms
TORRANCE, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Navitas Semiconductor (NASDAQ:NVTS), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power
10-14 04:39
出事了,美国摩根、瑞银竟同时出手,疯狂买入稀土唯一低估大龙头
（来源：财报翻译官） 风险提示：本文为财报教学文章，不包含推荐行为，请勿据此操作，注意安全。 一、美资巨头为何突然“相中”中国瑞林？ 要说这摩根史丹利和瑞银...
10-06 10:55
ULVAC, Inc. Considers Lowering Investment Units to Boost Market Participation
The latest announcement is out from ULVAC ( ($JP:6728) ). ULVAC, Inc. has annou...
09-26 14:55
Elanco Announces FDA Approves Improved Zenrelia™ (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language
FDA now concludes "the totality of evidence supports removal of the risk of fatal vaccine-induced disease from modified live virus vaccines from the labeling"i Further evaluation of suppleme...
09-23 18:27
Marriott Vacations Issues $575M Senior Notes for Debt
An announcement from Marriott Vacations Worldwide Corporation ( ($VAC) ) is now...
09-19 18:28
AbbVie's VRAYLAR Now Listed On Alberta Health Drug Formulary, Expanding Access To Mental Illness Treatment In Canada
VRAYLAR® is an atypical antipsychotic medication with partial agonist activity at central dopamine D3 receptors in addition to targeted activity at D2 and serotonin 5-HT1A and 5-HT2A receptors.1MONTREAL, Sept. 15,
09-15 21:04
